Valbiotis

Valbiotis Overview

Founded 2014
Founded
Status Public
Employees 36
Employees
Stock Symbol ALVAL
Stock Symbol
Share Price $4.39 (As of Tuesday Closing)

Valbiotis General Information

Description

Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Services
Stock Exchange
PAR
Primary Office
  • 40 rue Chef de Baie
  • 17000 La Rochelle
  • France
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Valbiotis Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.39 $4.43 $2.19 - $6.05 $31.6M 7.19M 30.5K -$1.31

Valbiotis Financials Summary

In Thousands,
USD
TTM 31-Dec-2019 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 18,779 18,779 8,219 14,854
Revenue 1,466 1,466 1,728 555
EBITDA (4,896) (4,896) (5,606) (2,594)
Net Income (6,161) (6,161) (5,861) (2,755)
Total Assets 16,869 16,869 13,619 15,251
Total Debt 5,350 5,350 3,205 2,031
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Valbiotis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Valbiotis‘s full profile, request access.

Request a free trial

Valbiotis Executive Team (3)

Name Title Board Seat Contact Info
Sébastien Peltier Co-Founder & Chief Executive Officer
Jocelyn Pineau Co-Founder & Chief Financial Officer
Philippe Charier Co-Founder & Director, Marketing

Valbiotis Board Members (1)

Name Representing Role Since
Laurent Levy Ph.D Self Chairman 000 0000